The first treatment of its kind for metastatic NSCLC, Optune Lua is approved for use concurrently with PD-1/PD-L1 inhibitors or docetaxel in adult patients with metastatic NSCLC who progressed on or ...
Optune Lua is now approved for use concurrently with immune checkpoint inhibitors or docetaxel in adult patients with metastatic NSCLC who have progressed on or after a platinum-based regimen CE Mark ...
Try running this:<BR><pre class="ip-ubbcode-code-pre">lua -e 'print(math.random(2147483648,2147483648))'</pre><BR><BR>I get:<BR><pre class="ip-ubbcode-code-pre ...
Optune Lua received a CE Mark for treating metastatic NSCLC, used with immune checkpoint inhibitors or docetaxel after progression on a platinum-based regimen. The phase 3 LUNAR trial showed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback